| Jessica Workman, PHARM D, RPH | |
|
176 Medical Center Dr, Rainelle, WV 25962-1064 | |
| (304) 438-6188 | |
| (304) 438-6819 |
| Full Name | Jessica Workman |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 176 Medical Center Dr, Rainelle, West Virginia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1912256959 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 7879 (West Virginia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Jessica Workman, PHARM D, RPH 176 Medical Center Dr, Rainelle, WV 25962-1064 Ph: (304) 438-6188 | Jessica Workman, PHARM D, RPH 176 Medical Center Dr, Rainelle, WV 25962-1064 Ph: (304) 438-6188 |
News Archive
A new study compares two surgical approaches to endoscopic thyroid removal, neither of which produces a scar in the neck area, providing a comprehensive comparison of the therapeutic effects and cosmetic results of each approach.
A new analysis conducted by the African Leaders Malaria Alliance, the Evidence to Policy Initiative at the University of California-San Francisco, and the Clinton Health Access Initiative "warns that if the countries that have produced impressive reductions in malaria cut or stop control activities, malaria will rapidly resurge and a decade of progress will have been in vain," BMJ News reports.
When the human genome sequence was launched in 2000, it introduced the possibility of personalisation in health care. Such personalisation can be applied to nutrition, a key health determinant, to create a diet tailored specifically for an individual, according to their individual physical and genetic make-up. Food4Me is a new, EU (FP7) funded project investigating the potential of this personalised nutrition.
A new genetic mutation that causes familial amyotrophic lateral sclerosis (ALS), a fatal neurological disorder also known as Lou Gehrig's Disease, has been identified by a team of scientists led by researchers at the University of Massachusetts Medical School (UMMS).
Bayer HealthCare announced today that the New Drug Application for its oral investigational compound riociguat has been accepted for filing and granted priority review by the U.S. Food and Drug Administration for the treatment of inoperable chronic thromboembolic pulmonary hypertension or with persistent or recurrent CTEPH after pulmonary endarterectomy and pulmonary arterial hypertension.
› Verified 5 days ago
Matthew Young, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 200 Kanawha Ave, Rainelle, WV 25962 Phone: 304-438-9204 Fax: 304-438-5122 | |
Yale Mendelson, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1250 Kanawha Ave, Rainelle, WV 25962 Phone: 304-438-9204 | |
Viola Marie Roush, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 645 Kanawha Ave, Rainelle, WV 25962 Phone: 304-438-6186 Fax: 304-438-6185 | |
David A Brown, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 406 John Raine Dr, Rainelle, WV 25962 Phone: 304-438-7182 | |
Dr. David Roland Yoakum Jr., PHARMD, CDE Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 176 Medical Center Dr, Rainelle, WV 25962 Phone: 304-438-6186 Fax: 304-438-6185 | |
Nicole Alison Young, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 200 Kanawha Ave, Rainelle, WV 25962 Phone: 304-438-9204 |